In a world plagued by shortages of water, three facts stand out in an analysis by Cornell ecologists: Less than 1 percent of water on the planet is fresh water; agriculture in the United States consumes 80 percent of the available fresh water.
Exactly what governs the motions of falling paper? While college students suspect the answer is known to lazy professors – the ones who allegedly grade essays by throwing them down stairwells to see which sails the farthest.
A just-released report to a bipartisan Congressional commission documented 48,417 U.S. jobs outsourced to other countries or publicly announced as being scheduled for outsourcing, from January through March 2004.
Calling all seniors: Cornell University gerontologists are looking for people 60 years of age or older who are willing to share what life has taught them.
A substantial number of older persons are physically or mentally abused, and mistreated seniors are three times more likely to die within three years than those who are not abused, a study done for Cornell researchers.
For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.
Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.
Without enough estrogen-like hormone in their systems, female plainfin midshipman fish turn a deaf ear to the alluring love songs of the males. And, according to Cornell biologists, a similar steroid-sensitive response could underlie changes in the hearing sensitivity of humans.
Researchers at NewYork-Presbyterian/Weill Cornell Report Findings of Phase I Clinical Trial of Monoclonal Antibody Treatment for Advanced Prostate Cancer.
